Skip to main content
. 2018 Aug 30;8:13103. doi: 10.1038/s41598-018-31288-7

Figure 3.

Figure 3

Characterization of bone marrow from WT and Ats1-KO mice. (a) Graph representing flow cytometry data, as percentage of positive cells of the following populations: CD45R+, CD3+, CD11b+, GR1+, CD11b+/GR1+, and F4/80+, found in bone marrow of healthy WT (n = 5) and Ats1-KO (n = 5) mice. (b) Graph representing the mRNA fold change expression of Cd3g, Il12a, Cd11b, Cd163 and Nos2 genes in bone marrow of healthy WT (n = 5) and Ats1-KO (n = 5) mice, being all values relative to WT. (c) Western blot analysis with anti-DPEAAE antibody for ADAMTS-cleaved versican in BM protein extracts from WT and Ats1-KO mice. Blue arrows indicate predicted versican (V0/V1) fragments (around 220 kDa and 70 kDa). Bottom panel includes tubulin staining (grey arrow). Full-length blots are presented in Supplementary Figure 5. (d) Graph representing the absolute Ct value for mRNA expression of Adamts1, 4, 5, 9, 15, and 20 genes in bone marrow of healthy WT (n = 6) and Ats1-KO (n = 5) mice (values higher than 37–38 are considered very low or absent). For all the graphs, results are shown as the median with s.e.m. and statistical significance (*p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001).